In the eBook, industry leaders Validic, Biogen, Pfizer and Medidata discuss how digital health is disrupting the way the pharmaceutical industry gathers data from clinical trial participants. By arming participants with wearable and FDA Class II medical devices, sensors and applications, pharma and CROs can remotely collect activity data along with key biometrics.
This stands to significantly restructure the drug development process, allowing companies to bring a drug to market more efficiently and cost-effectively while also improving the clinical trial participants’ experience.
Pharmaceutical companies looking to implement a digital health strategy can download this free white paper today to:
- Learn four key ways pharma and CROs can leverage participant data from digital health devices.
- Read real examples of how digital health data is being utilized by pharma.
- Discover the benefits, for both pharma and trial participants, of integrating digital health data into drug development.